Why did Meta offer $100M to AI researchers?
How are U.S. tariffs affecting Nike’s costs?
What impact will AI have on Salesforce jobs?
Why did Trump drop 'Made in USA' phone label?
How does the U.S.-China trade deal affect markets?
Why are investors flocking to AI-related stocks?
How did recovery of Air India black boxes impact investigation?
Can Biogen Outdo Its Own Spinal Muscular Atrophy Drug?
investors.com/news/technology/biogen-next-generation-spinraza-spinal-muscular-atrophy-treatment
Biogen said Wednesday its experimental treatment helped children with SMA even after they received an approved gene therapy from Novartis.
The post Can Biogen Outdo Its Own Spinal Muscular Atrophy Drug? appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-06-25 11:30:19.